Insider Trading Summary for Vertex Pharmaceuticals Inc. (VRTX): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Aug-24 4:10 PM View:	01-Aug-24 Planned Option Sale ($2.69M)	Sachs Bruce I Director		Vertex Pharmaceuticals Inc. - VRTX	0% 40.0K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 4:12 PM View:	30-Aug-24 Planned Option Sale ($323.00K)	Bhatia Sangeeta N. Director		Vertex Pharmaceuticals Inc. - VRTX	14% 3.9K to 4.43K	0	0	--	--	Show Txns Hide Txns

03-May-24 4:09 PM View:	01-May-24 Grant 0	Carney Lloyd Director		Vertex Pharmaceuticals Inc. - VRTX	19% 5.32K to 6.32K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 4:13 PM View:	30-Aug-24 Private Sale (Planned) ($1.89M)	Leiden Jeffrey M Executive Chairman Director		Vertex Pharmaceuticals Inc. - VRTX	(54%) 22.86K to 10.43K	0	0	--	--	Show Txns Hide Txns

01-Aug-24 4:17 PM View:	30-Jul-24 Private Sale (Planned) ($7.68M)	Kewalramani Reshma CEO & President Director		Vertex Pharmaceuticals Inc. - VRTX	(20%) 113.81K to 90.97K	0	0	--	--	Show Txns Hide Txns

08-Aug-24 4:06 PM View:	07-Aug-24 Private Sale (Planned) ($1.09M)	Bozic Carmen EVP and CMO		Vertex Pharmaceuticals Inc. - VRTX	(21%) 29.3K to 23.26K	0	0	--	--	Show Txns Hide Txns

03-May-24 4:18 PM View:	01-May-24 Disposition 0	McKenzie Diana Director		Vertex Pharmaceuticals Inc. - VRTX	(6%) 2.81K to 2.64K	0	0	--	--	Show Txns Hide Txns

05-Jun-24 4:11 PM View:	03-Jun-24 Private Sale (Planned) ($1.50M)	Wagner Charles F Jr EVP & Chief Financial Officer		Vertex Pharmaceuticals Inc. - VRTX	1% 46.69K to 47.14K	0	0	--	--	Show Txns Hide Txns

05-Jun-24 4:08 PM View:	03-Jun-24 Private Sale (Planned) ($1.00M)	Tatsis Ourania EVP, Chief Reg. & Quality Off.		Vertex Pharmaceuticals Inc. - VRTX	1% 48.64K to 49.1K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 4:02 PM View:	02-Apr-24 Sale (Planned) ($100.56K)	Ambrose Kristen SVP & Chief Accounting Officer		Vertex Pharmaceuticals Inc. - VRTX	10% 6.84K to 7.5K	0	0	--	--	Show Txns Hide Txns

17-May-24 4:24 PM View:	15-May-24 Private Sale (Planned) ($29.73K)	Arbuckle Stuart A EVP, COO		Vertex Pharmaceuticals Inc. - VRTX	(12%) 56.7K to 49.83K	0	0	--	--	Show Txns Hide Txns

03-May-24 4:26 PM View:	01-May-24 Disposition 0	Upadhyay Suketu Director		Vertex Pharmaceuticals Inc. - VRTX	(6%) 2.73K to 2.56K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 4:56 PM View:	12-Feb-24 Sale (Planned) ($727.82K)	Biller Jonathan EVP and Chief Legal Officer		Vertex Pharmaceuticals Inc. - VRTX	73% 10.57K to 18.28K	0	0	--	--	Show Txns Hide Txns

13-Jun-24 4:09 PM View:	12-Jun-24 Sale (Planned) ($3.48M)	Atkinson Edward Morrow III EVP, Chief Technical Ops. Off.		Vertex Pharmaceuticals Inc. - VRTX	15% 13.88K to 15.97K	0	0	--	--	Show Txns Hide Txns

07-Jun-24 4:07 PM View:	05-Jun-24 Gift 0	Sachdev Amit EVP Chief Patient & Ext Af Off		Vertex Pharmaceuticals Inc. - VRTX	(12%) 66.26K to 58.17K	0	0	--	--	Show Txns Hide Txns

03-May-24 4:23 PM View:	01-May-24 Grant 0	Thornberry Nancy Director		Vertex Pharmaceuticals Inc. - VRTX	100% 0 to 1.64K	0	0	--	--	Show Txns Hide Txns

17-May-24 4:18 PM View:	15-May-24 Grant 0	Schneider Jennifer Director		Vertex Pharmaceuticals Inc. - VRTX	100% 0 to 0.92K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 4:08 PM View:	15-Nov-24 Private Sale (Planned) ($7.18K)	Altshuler David EVP, Chief Scientific Officer		Vertex Pharmaceuticals Inc. - VRTX	(19%) 32.04K to 25.81K	0	0	--	--	Show Txns Hide Txns

Vertex Pharmaceuticals Inc. (VRTX)

Last Year

22-Nov-23 -- 21-Nov-24

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--